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CORONARY ARTERY DISEASE 
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The Reykjavik Study 
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Reykjavik and Hafnarf~ordur, Iceland and GOteborg, Sweden 
Objectives. We sought to evaluate he prognostic value and dinical 
characteristics a sociated with electrocardiographic (ECG) ST-T 
changes among men without other manifestations of coronary heart 
disease. 
Background. Recent achievements in secondary prevention and 
treatment ofcoronary heart disease have highlighted the impor- 
tance of early diagnosis of both symptomatic and silent forms of 
the disease. The prognostic and clinical importance of ST-T 
changes in men with no other manifestations of coronary heart 
disease is still unclear. Do they reflect silent coronary heart 
disease or hypertension, orboth, and what is their independent 
contribution to prognosis? 
Methods. The subjects were 9,139 men born in the years 1907 to 
1934 and followed up for 4 to 24 years. On initial visit they were 
assigned to different categories of coronary heart disease on the 
basis of Rose chest pain questionnaire, hospital records, 12-lead 
ECG, history and physical examination. 
Results. The prevalence of silent ST-T changes among men 
without overt coronary heart disease was strongly influenced by 
age, increasing from 2% at age 40 years to 30% at age 80 years. 
Men with such ST-T changes were older and had higher serum 
triglyceride l vels and worse glucose tolerance than men without 
such changes or other evidence of coronary heart disease. Their 
blood pressure was higher, and they more often had an enlarged 
heart or left ventricnlar hypertrophy and more often took anti- 
hypertensive medication, digitalis or diuretic drugs. Serum cho- 
lesterol evels were not different between the two groups. After 
adjustment for other isk factors, these silent ST-T changes had a 
risk ratio of 2.0 for death from coronary heart disease and 1.6 for 
subsequent myocardial infarction or angina pectoris. 
Conclusions. Silent ST-T changes that are ischemic by the 
Minnesota code are probably both a marker of silent coronary 
heart disease and high blood pressure. They define a distinct 
group of patients with a highly abnormal risk factor profile. 
Although not specific for coronary heart disease and often tran- 
sient, they are associated with the development ofevery clinical 
manifestation of coronary heart disease and are independent 
predictors of reduced survival. 
(J Am CoU Cardiol 1996;27:1140-7) 
The rest electrocardiogram (ECG) has been used to diagnose 
coronary heart disease for nearly 100 years. It is a simple 
noninvasive method, useful both for diagnosing coronary heart 
disease in symptomatic patients and as a screening method. 
The ST segment and T wave changes are probably the most 
sensitive ECG changes, although they are not specific for 
coronary heart disease (1). Several epidemiologic studies (2-9) 
have shown an increased risk of death from coronary heart 
disease among men with "ischemic" ST-T wave changes. How- 
ever, although silent ischemia has been firmly established as an 
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important manifestation fcoronary heart disease (10,11), only a 
few epidemiologic studies (2,9) have specifically examined the 
group of patients with ischemic ST-T wave changes who do not 
have other manifestations of coronary heart disease as defined by 
questionnaire, ECG and physical examination. 
In previous reports we (12-14) described the epidemiologic 
features and long-term prognosis of different forms of coro- 
nary heart disease, including recognized and unrecognized 
myocardial infarction and three groups of angina pectoris. 
Recent successes in secondary prevention of coronary heart 
disease (15) have highlighted the importance ofearly diagnosis 
of both symptomatic and silent forms of the disease. We now 
report on a cohort of men participating in a large population- 
based cohort study who neither fulfilled the criteria of the Rose 
chest pain questionnaire for angina pectoris (16) nor had a 
history or ECG manifestations of myocardial infarction but 
had ST or T wave changes, or both, that although not specific 
for coronary heart disease are indicative of myocardial isch- 
emia according to the Minnesota code (17). The specific aims 
of the study were 1) to describe the clinical and biochemical 
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Table 1. Participants Invited and Examined inStages 1to 4 of the Reykjavik Study* 
Groups Selected for Future Invitation: December 1, 1966 
Group B Group C Group A Group D Group E 
(n = 2,955) (n : 2,743) (n - 2,756) (n : 2,283) (n : 2,106) 
Stage 1:1967-1968 2,942 
2,203 
Stage 2:1970-1971 2,869 
2,072 
Stage 3:1974-1977 2,787 
1,916 
Stage 4:1979-1981 2,637 
1,801 
Stage 5:1985-1987 2,389 
1,477 
2,681 
1,986 
2,564 
1,786 
2,592 
1,862 
2,046 
1,444 
1,734 
1,115 
*The numbers above the rules show the number of participants invited (the number alive at the beginning of each 
stage); the numbers below the rules show the number of those who were examined uring that stage. Group A to E = 
patients classified according to birth date. 
characteristics of this population-based cohort of men with 
silent ST-T changes in a standard ECG with respect o risk 
factors of coronary heart disease and concurrent disease; 2) to 
analyze the independent contribution ofthese ECG changes to 
the future development of angina and myocardial infarction 
and to coronary heart disease mortality after multiple con- 
founding factors had been accounted for; and 3) to compare the 
long-term prognosis of this group of patients with that of popu- 
lation cohorts with other specific overt forms of coronary heart 
disease. 
Methods 
Study design. The Reykjavik study, a large population- 
based cohort study begun in 1967, has been described in detail 
previously (12-14). The study plan is shown in Table 1. All men 
residing in the Reykjavik area on December 1, 1966 who were 
born in the years 1907 to 1934 (both years included) were 
classified into six groups, A to F, according to day and year of 
birth, to be invited to participate at various tages of the study. 
Men in five of these groups (A to E) were invited to participate 
one to five times during the years 1967 to 1987 (Table 1). 
Group F (participants born on the 3rd, 6th, 9th, etc., of each 
month), comparable to the other groups but as a form of 
control, was not invited to participate in the survey. Baseline 
measurements, including blood pressure measurements and 
diagnosis of hypertension, were obtained at each person's first 
visit (Table 1). The overall response rate was 71% but varied 
between 64% and 75% at different stages of the study. A total 
of 9,139 men participated in the study at least once. Women 
also participated (18) but are not included in this report. Every 
participant answered aquestionnaire, including the Rose chest 
pain questionnaire used by the London School of Hygiene and 
Tropical Medicine (16). Participants were examined by a 
physician, blood tests were obtained after overnight fasting, a 
chest roentgenogram was taken in two planes and a standard- 
ized 12-lead ECG was recorded and evaluated according to the 
Minnesota code criteria (17). Data regarding the incidence of 
myocardial infarction have been collected since 1981 as a part 
of the World Health Organization MONICA Project (19). For 
persons who had a myocardial infarction before 1981, hospital 
records were reviewed and evaluated according to the criteria 
used in the MONICA study. The incidence of various catego- 
ries of overt coronary heart disease was obtained from 3,737 
pairs of visits at consecutive stages of the study. 
Causes of death were determined by review of all death 
certificates from the start of the study until December 31, 1992. 
Additionally, all autopsy records were reviewed (the autopsy 
rate was 55%). 
On the basis of answers to the Rose questionnaire, r view 
of hospital records, physical examination and the ECG, the 
participants were classified into the following diagnostic ate- 
gories: 
Group L Recognized myocardial infarction: subjects who 
fulfilled the MONICA criteria for definite myocardial infarc- 
tion (19). These criteria include 1) ECG changes (Minnesota 
codes 1.1.1 to 1.2.8), 2) symptoms that are typical or atypical or 
inadequately described together with probable ECG changes 
and abnormal serum cardiac enzyme levels, or 3) typical 
symptoms and abnormal enzyme l vels with an ECG indicative 
of ischemia or noncodable. 
Group II. Unrecognized myocardial infarction: participants 
with no history or symptoms of a heart attack but with ECG 
changes fulfilling the criteria for definite myocardial infarction 
(Minnesota codes 1.1.1 to 1.2.8). 
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Group III. Angina pectoris with ECG changes of myocardial 
ischemia: participants with no history or ECG manifestations 
of myocardial infarction who fulfilled the criteria of the Rose 
questionnaire for angina pectoris and had either ischcmic 
ECG changes (Minnesota codes 1.3.1 to 1.3.6, 4.1 to 4.4, 5.1 to 
5.4) or normal findings on a rest ECG with positive findings on 
an exercise stress test (->0.2-mV horizontal or downsloping ST 
segment depression). 
Group IV. Angina pectoris with normal rest ECG: partici- 
pants with no manifestations of myocardial infarction who 
fulfilled the criteria of the Rose questionnaire for angina 
pectoris but had normal findings on a rest ECG and either had 
normal findings on an exercise test or did not undergo an 
exercise test. The diagnosis was supported by the clinical 
judgment of the examining doctor. 
Group V. Angina pectoris by Rose questionnaire only: partic- 
ipants with a normal rest or exercise ECG who fulfilled the 
criteria of the Rose chest pain questionnaire for angina 
pectoris, although the investigating doctor using clinical judg- 
ment could not confirm the diagnosis. 
Group VI. Silent ST-T changes on a rest ECG: participants 
who did not fulfill the criteria of the Rose chest pain question- 
naire for angina pectoris, had no history or ECG manifesta- 
tions of myocardial infarction but had ST-T wave changes in a 
rest ECG indicative of myocardial ischemia (Minnesota codes 
4.1 to 4.4, 5.1 to 5.4). 
Group VII. No coronary heart disease: participants with no 
history, symptoms or ECG manifestations of coronary heart 
disease. 
Participants in group VI (no history or symptoms of coro- 
nary heart disease but iscfiemic ST-T wave changes in the rest 
ECG by Minnesota code) are the subjects of this report. 
However, as described earlier, this group was defined by 
exclusion of symptomatic forms of coronary heart disease as 
well as exclusion of ECG manifestations of unrecognized 
myocardial infarction. 
Hypertension was defined as systolic blood pressure 
->160 mm Hg or diastolic blood pressure ->95 mm Hg, or both, 
or use of antihypertensive medication. Left ventricular hyper- 
trophy was defined as R wave amplitude 1) >26 mm in lead V 5 
or V6; 2) >20 mm in lead I, II, III or aVF; or 3) >12 mm in 
lead aVL. 
Statistical methods. Univariate analysis was applied to 
compute the significance of differences in mean values of the 
variables between group VI (silent ST-T changes with no other 
evidence of coronary heart disease) and group VII (no such 
changes and no other evidence of coronary heart disease). The 
results from each person's first visit were used and those having 
a diagnosis of coronary heart disease were excluded. 
The variables hown in Table 2 were used in the subsequent 
multivariate analysis, but only those showing a significance 
level <0.05 were entered in the final equations. Multivariate 
logistic regression was applied to the same data to compute the 
dependence of ST-T changes on simultaneous values of the 
measured variables. For persons in the study having a second 
visit, pairs of visits were used in a multivariate Poisson 
regression to compute the predictive power of measured 
variables on later development of coronary heart disease 
(either myocardial infarction or angina pectoris). Participants 
who had a diagnosis of coronary heart disease in their first visit 
were excluded. 
Multivariate Cox regression was used 1) to estimate the 
independent contribution of variables measured uring each 
person's first visit to the risk of death from coronary heart 
disease, and 2) to calculate survival probability. In this analysis 
those having a diagnosis of coronary heart disease were 
included and the various diagnoses added as risk factors. 
Results  
Clinical characteristics. Table 2 compares the mean values 
of the clinical characteristics of men in group VI (silent ST-T 
changes with no other evidence of coronary heart disease) and 
men in group VII (no coronary heart disease, defined as no 
silent ST-T changes and no other evidence of coronary heart 
disease). The men with silent ST-T changes were older, had 
higher serum triglyceride l vels and body mass index and worse 
glucose tolerance. Their blood pressure (both diastolic and 
systolic) was much higher, and 59% fulfilled the criteria for 
hypertension in contrast to 27% of men with no coronary heart 
disease (confidence interval [CI] for differences in mean value 
28 to 37, p < 0.0001). Cardiomegaly, defined as heart size 
>550 cm//m 2body surface area, was present in 15.9% of men 
with versus 4.5% in men with no coronary heart disease (p < 
0.0001), and the ECG criteria for left ventricular hypertrophy 
were met in 12% versus 3%, respectively. There were no 
differences in cholesterol levels between groups. 
The mean percentage ofmen taking digitalis, diuretic drugs 
or other antihypertensive medication according to diagnostic 
categories i  shown in Figure 1. Of the men with silent ST-T 
changes (group VI), 20% were treated for hypertension, 4% 
were taking diuretic drugs and 5% were taking digitalis. The 
corresponding numbers for those with no coronary heart 
disease (group VII) were 5%, 0.3% and 0.6%, respectively 
(p < 0.0001 in all cases, Table 2). 
Factors found to be significantly correlated with silent ST-T 
changes by multivariate logistic regression analysis are shown 
in Table 3. These included treatment with a diuretic drug or 
digitalis and treatment for hypertension, as well as both 
diastolic and systolic blood pressure, cardiomegaly on chest 
roentgenogram and left ventricular hypertrophy by ECG. 
Cigarette smoking also had a significant correlation. 
Table 4 shows the results of a Poisson multivariate r gres- 
sion analysis on the predictive power of several variables on 
future development of angina or myocardial infarction. Treat- 
ment with a diuretic drug or digitalis had the strongest 
predictive power on future development of coronary heart 
disease, followed by serum cholesterol level, triglyceride level 
and age. Smoking was also a strong predictor, the power 
increasing with the number of cigarettes moked/day. Silent 
ST-T changes in themselves carried a 1.6 (95% CI 1.0 to 2.8) 
relative risk of development of either angina pectoris or 
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Table 2. Mean Values of Clinical Characteristics: Group VI* Versus Group VI I t  
Group VI 
Mean SD 
Group VII 95% CI for 
Differences in p 
Mean SD Mean Value Value 
Number of men 437 
Age (yr) 57.7 
Calendar year 1976.2 
Cholesterol (mg/dl) 245.6 
Triglycerides (mg/dl) 124 
Blood glucose at 90 min (mg/dl) 118 
Systolic blood pressure (mm Hg) 156 
Diastolic blood pressure (mm Hg) 95 
Hypertension (%) 59 
Left ventricular hypertrophy by ECG (%) 12 
Height (cm) 175.1 
Weight (kg) 82.0 
Body mass index (kg/m 2) 26.7 
Fasting blood glucose (mg/dl) 86.3 
Hematocrit (%) 45.7 
Uric acid (mg/dl) 57.1 
Sedimentation rate (ram/h) 9.1 
Cardiomegaly (%) 15.9 
Smoking habits (%) 
Never 20 
Former 30 
Pipe/cigars 19 
Cigarettes 
<15/day 10 
15 to 24/day 15 
->25/day 6 
Taking antihypertensive medication (%) 20 
Taking diuretic drugs (%) 4 
Taking digoxin (%) 5 
7,903 
9.1 51.6 8.3 5.2 to 7.0 < 0.0001 
6.3 1974.2 5.9 1.4 to 2.6 > 0.0001 
41.9 246.0 41.2 -4.4 to 3.6 0.85 
81 108 60 8 to 24 < 0.0001 
46 101 35 13 to 21 < 0.0001 
25 139 18 15 to 19 < 0.0001 
14 88 10 6 to 8 < 0.0001 
27 28 to 37 < 0.0001 
3 6 to 12 < 0.0001 
6.2 176.6 6.3 -2.1 to -0.9 < 0.0001 
13.5 80.3 12.0 0.4 to 3.0 < 0.01 
4.0 25.7 3.4 0.6 to 1.4 < 0.0001 
22.4 82.6 13.7 1.6 to 5.8 < 0.001 
3.4 45.6 2.9 -0.2 to 0.4 0.55 
12.1 53.5 10.6 2.9 to 4.3 < 0001 
10.1 6.8 7.9 1.3 to 3.3 < 0.0001 
4.5 8 to 15 < 0.0001 
22 -6  to 2 0.25 
24 2 to 11 0.003 
25 - 10 to - 2 0.003 
11 -4  to 2 0.47 
13 -1 to 6 0.13 
6 -2  to 2 0.89 
5 11 to 19 < 0.0001 
0.3 2 to 5 0.0002 
0.6 2 to 6 < 0.0001 
*Group VI comprises men with silent ST-T changes and no other evidence of coronary heart disease. ?Group VII comprises men with no silent ST-T changes and 
no other evidence of coronary heart disease. CI = confidence interval. 
myocardial infarction when all other factors had been ac- 
counted for. Serum cholesterol, age and silent ST-T changes 
were significantly associated with increased risk of having a 
myocardial infarction (risk ratio 1.014 per mg/dl, 1.082/year 
and 3.4, respectively). 
Prevalence. The prevalence of silent ST-T changes was 
highly influenced by age; it was 2% at age 40 years, 4% at age 
50 and 9%, 17% and 30% at age 60, 70 and 80, respectively. 
Prognosis. Cox regression analysis was used to calculate 
the independent contribution of measured variables at each 
person's first visit to the risk of dying from coronary heart 
disease (Table 5). Participants having a diagnosis of coronary 
heart disease were included and the various diagnoses were 
added as risk factors. Recognized and unrecognized myocar- 
dial infarction was associated with a risk ratio of 8.0 and 7.0, 
respectively, when the various risk factors had been accounted 
for. The angina groups had 2.3-fold to 3.9-fold risk of death 
from coronary heart disease, whereas silent ST-T changes 
(group VI) carried a 2.0-fold risk compared with that of men 
with no coronary heart disease (group VII). As shown in Table 
6, the presence of ST-T changes greatly increased the risk of 
death from coronary heart disease among those having angina 
Figure 1. Mean percentage of men in the seven diagnostic groups 
taking digitalis, diuretic drugs or other antihypertensive medication. 
I = recognized myocardial infarction. II = unrecognized myocardial 
infarction. III = angina pectoris with electrocardiographic (ECG) 
changes of myocardial ischemia. IV = angina pectoris with normal rest 
ECG. V = angina pectoris by Rose questionnaire only. V! = silent 
ST-T changes or rest ECG. VII = no coronary heart disease. Open 
bars = digitalis; solid bars = diuretic; striped bars = antihypertensive 
therapy. 
25 
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Table 3. Factors Correlating Significantly With Silent ST-T Changes: Cross-Sectional Study With 
Multivariate Logistic Regression (n = 8,345)* 
P 
Mean SD Odds Ratio 95% CI Value 
Diuretic drug (%) 0.5 
Digitalis (%) 0.8 
Cardiomegaly (%) 5 
Antihypertensive medication (%) 6 
Systolic blood pressure (ram Hg) 140 
Diastolic blood pressure (mm Hg) 88 
Blood glucose at 90 rain (mg/dl) 102 
Age (yr) 52 
Smoking habits (%) 
Never 22 
Former 24 
Pipe and cigars 25 
Cigarettes 
1 to 14/day 11 
15 to 24/day 13 
->25/day 6 
Left ventricular hypertrophy by ECG 3 
*Persons with a diagnosis of coronary heart 
electrocardiography. 
19 
10 
36 
8 
4.5 2.1 to 9.8 < 0.001 
4.8 2.6 to 8.8 < 0.001 
2.0 1.4 to 2.7 < 0.001 
1.6 1.2 to 2.1 0.003 
1.02 1.01 to 1.03 < 0.001 
1.02 1.00 to 1.03 0.02 
1.003 1.001 to 1.003 0.005 
1.060 1.046 to 1.074 < 0.001 
1.0 
1.3 1.0tol.8 0.07 
1.3 1.0tol.8 0.13 
1.5 1.0to2.2 0.06 
2.3 1.6to3.3 <0.001 
2.1 1.3to3.3 0.003 
2.6 1.8to3.7 <0.001 
disease diagnosis were excluded. CI = confidence interval; ECG = 
or a history of myocardial infarction. Table 6 also shows the 
mortality risk in different diagnostic ategories with or without 
ST-T changes, emphasizing the independent prognostic effect 
of angina and myocardial infarction over and above the ECG 
manifestations of ischemia. The combination of silent ST-T 
changes and hypertension did not add significantly to the risk 
that each carried separately. 
Figure 2 shows the Kaplan-Meier survival probability with 
respect to coronary heart disease mortality of the different 
diagnostic groups after correction had been made for differ- 
ences in risk factor profiles. The significance of differences in 
risk among the diagnostic groups was tested by Cox regression 
analysis. There was no significant difference between recog- 
nized and unrecognized myocardial infarction. However, myo- 
cardial infarction carried a significantly higher risk than that of 
the angina groups, and the angina groups carried a significantly 
higher risk than that of group VI (silent ST-T changes). Group 
VI defined a survival ine that was distinctly worse than that of 
men who had no coronary heart disease (group VII). Coronary 
heart disease was the cause of death in 50% of cases in group 
VI versus 34% among men in group VII. 
The subsequent clinical course of the men with silent ST-T 
changes is presented in Figure 3. The time between ensuing 
visits ranged from 2 to 5 years. Ten percent of men initially in 
this group were subsequently classified in one of the coronary 
heart diagnostic groups. Of those who attended, 36% showed 
Table 4. Predictive Power of Several Variables on Future Development of Angina or Myocardial 
Infarction: Multivariate Poisson Regression (n = 3,535 pairs of visits) 
P 
Mean SD Risk Ratio 95% CI Value 
Diuretic drug (%) 0.3 
Digitalis (%) 1.0 
Cholesterol (mg/dl) 250 
Triglycerides (mg/dl) 102 
Age (yr) 50 
Calendar year 1971 
Smoking (%) 
Never 21 
Former 19 
Pipe/cigars 28 
Cigarettes 
<15/day 12 
15 to 24/day 13 
>-25/day 6 
Silent ischemic ST-T changes 4 
CI = confidence interval. 
4.3 1.4to13,5 0.01 
4.2 1.8to10,0 0.001 
43 1.007 1.004 to 1.010 < 0.001 
53 1.003 1.00 m 1.005 0.02 
7 1.068 1.045 to 1.092 < 0.001 
3 0.90 0.84to0.96 0.001 
1.0 
1.1 0.7tol.8 0.68 
1.4 0.9t02.2 0.10 
1.4 0.8to2.3 0.26 
1.6 1.0to2.7 0.07 
2.4 1.3to4.4 0.0N 
1.6 1.0to2.8 0.07 
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Table 5. Relative Risk of Death From Coronary Heart Disease: 
Multivariate Cox Regression (n = 9,139) 
Risk p 
Ratio 95% CI Value 
Cholesterol (mg/dl) 1.006 1.004 to 1.008 < 0.(301 
Blood glucose, fasting (mg/dl) 1.006 1.003 to 1.010 < 0.001 
Height (m) 0.98 0.97 to 0.99 0.002 
Age (yr) 1.088 1.077 to 1.100 < 0.00l 
Smoking habits (%) 
Never 1.0 
Former 1.2 0.9 to 1.5 0.12 
Pipe/cigars 1.6 1.3 to 1.9 < 0.001 
Cigarettes 
1 to 14/day 1.8 1.4 to 2.4 < 0.001 
15 to 24/day 1.9 1.5 to 2.5 < 0.001 
->25/day 2.0 1.4 to 2.7 < 0.001 
Diagnostic categories 
No CHD 1.0 
Recognized MI 8.0 6.1 to 10.4 < 0.001 
Unrecognized M1 7.0 4.9 to 10.0 < 0.001 
Angina with ECG changes 3.9 2.9 to 5.1 < 0.001 
Angina without ECG changes 2.3 1.6 to 3.4 < 0.001 
Angina by Rose questionnaire only 2.6 1.9 to 3.5 < 0.001 
Silent Ischemic ST-T changes 2.0 1.6 to 2.5 < 0.001 
Calendar year 0.97 0.95 to 0.97 0.003 
Triglycerides (mg/dl) 1.001 1.001 to 1.002 0.002 
Hematocrit (%) 1.05 1.03 to 1.08 < 0.001 
Sedimentation rate (ram/h) 1.03 1.02 to 1.03 < 0.001 
Digitalis 1.7 1.2 to 2.3 < 0.001 
Systolic blood pressure (mm Hg) 1.010 1.007 to 1.013 < 0.001 
CHD = coronary heart disease; MI = myocardial infarction; other abbre- 
viations as in Table 3. 
no ischemic hanges at the next stage of the study, 9% fulfilled 
the criteria for angina pectoris and 5% had had myocardial 
infarction. 
Discussion 
The results of this large population-based cohort study 
show that silent ischemic ST-T changes among men without 
Table 6. Relative Risk of Coronary Heart Disease Death in 
Different Patient Groups With or Without ST-T Changes: 
Multivariate Cox Regression With Adjustment for All Risk 
Factors Shown in Table 2 (n = 9,139) 
P 
Diagnostic Category* Risk Ratio 95% CI Value 
Without ST-T changes 
No CHD 1.0 
Angina 2.5 2.0 to 3.2 < 0.0001 
MI 5.6 4.0 to 7.8 < 0.0001 
With ST-T changes 
No CHD 2.0 1.6 to 2.6 < 0.0001 
Angina 4.2 3.1 to 5.7 < 0.0001 
MI 9.9 7.6 to 13.0 < 0.0001 
*Patients with unrecognized and recognized myocardial infarction were 
grouped together, as were patients with angina pectoris. Abbreviations as in 
Tables 2 and 5. 
100 
p 9O 
E 80  
R 70  
C 60  
E 
5O 
N 
T 40  
A 3O 
G 2O 
E 10 
0 
••.•.•.• 
"vii 
"~- IV 
I 
I I I i I I I I I ] I I [ I I I I I [ I 
2 4 6 8 10 12 14 16 18 20 
YEARS 
F igure  2. Survival probability with respect o death from coronary 
heart disease in men in diagnostic groups I to VII, after adjustment for 
differences in risk factor profile. Diagnostic groups as in Figure 1. 
any other manifestations of coronary heart disease (group VI) 
doubled the risk of death from coronary heart disease even 
after multiple confounding factors had been accounted for. In 
the selected group of those having angina pectoris or myocar- 
dial infarction, the presence of ST-T changes also nearly 
doubled the risk of coronary heart disease mortality. The 
prevalence of silent ST-T changes was strongly dependent on 
age, ranging from 2% at age 40 years to 30% at age 80 years. 
Men with such changes (group VI) were older, had higher 
serum triglyceride l vels, were more often treated for high blood 
Figure 3. Subsequent clinical course of men having silent ST-T 
changes on the rest electrocardiogram (ECG) in diagnostic group VI. 
Data indicate reclassification at the ensuing stage of the Reykjavik 
Study based on clinical and ECG data obtained at that stage. 
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No evidence of coronary heart disease 
by queedonnaJre, hospital records or ECG 
Death 
Not attended. (Follow-up information complete}. 
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pressure and took digitalis and diuretic drugs more often than 
did men with no coronary heart disease (group VII). Further- 
more, their blood pressure, both systolic and diastolic, was 
significantly higher and 59% of the group was by definition 
hypertensive incontrast to 27% in the group with no coronary 
heart disease. They more often had left ventricular hypertro- 
phy and cardiomegaly by chest roentgenogram. 
Possible mechanisms of silent ST-T changes. Studies have 
repeatedly shown that ischemic ST-T changes, even though 
strictly defined by the Minnesota code, are not specific for 
coronary heart disease and can be seen in individuals without 
such disease. Among the many known causes are T wave 
inversions recorded in young adults (juvenile pattern), electro- 
lyte disturbances, valvular heart disease, cardiomyopathy, 
drugs, intracranial lesions, hyperventilation a d recent food 
ingestion (1). 
In the present study a strong association was found between 
silent ST-T changes and the use of digitalis and diuretic drugs 
as well as the known risk factors of coronary heart disease 
(Table 3). Furthermore, ->36% of the men with silent ST-T 
changes did not display these changes at the ensuing stage of 
the study, an observation supporting results from other surveys 
(20). The Framingham study (20) showed that nonspecific 
ECG abnormalities--defined as ST segment depression 
>1 mm or T wave flattening or inversion in leads where this 
should not occur in the absence of increased R wave, or 
both--tended tobe transient. The changes were persistent in
only 50% of subjects in that study. 
The fact that these ECG changes are often transient and 
not specific, together with a strong relation with high blood 
pressure, makes it difficult to determine their precise patho- 
physiologic mechanism. Do they indicate silent myocardial 
ischemia or high blood pressure, or both. 9 Hypertension affects 
the heart by inducing both left ventricular hypertrophy and 
obstructive coronary artery disease (21). The left ventricular 
hypertrophy is associated with increased myocardial oxygen 
demand and reduced coronary blood flow reserve. Further- 
more, when coronary heart disease is associated with hyper- 
tension and left ventricular hypertrophy, the impact of the 
coronary atherosclerosis is exacerbated (21). 
Prognostic importance of silent ST-T changes. In the 
present study, there was a strong association between silent 
ST-T changes and blood pressure, indicating that these 
changes are in part a marker of hypertension. Nearly 20% of 
men with silent ST-T changes were receiving treatment for 
high blood pressure and had markedly elevated systolic and 
diastolic blood pressure. However, after accounting for blood 
pressure, hypertensive treatment and treatment with digitalis 
and diuretic drugs as well as other isk factors, an independent 
contribution toprognosis persisted, causing atwo-fold increase 
in relative risk of death from coronary heart disease. Further- 
more, 18% of the men with silent ST-T changes on the rest 
ECG who were examined in the next stage of the study were 
then classified as having manifest coronary heart disease 
(either myocardial infarction or angina pectoris). By multivar- 
iate Poisson regression analysis they had a 1.6-fold increased 
risk for development of angina or myocardial infarction (Table 
4). 
Previous studies. Electrocardiographic abnormalities a a 
predictor of sudden cardiac death have been the subject of 
several studies. Rabkin and co-workers (9) analyzed the ECGs 
of 70 victims of sudden death with no prior clinical evidence of 
coronary heart disease in a cohort of 3,983 men. Of these 70 
men, 71.4% had previous ECG abnormalities--most fre- 
quently ST segment or T wave abnormalities (50%). These 
"ischemic ST-T changes" were clearly associated with in- 
creased risk of sudden death. Analysis of the Framingham data 
(2) also revealed that ST segment and T wave changes 
(classified as nonspecifie ST-T abnormalities) were associated 
with increased risk of sudden cardiac death. Almost wo thirds 
of those who died suddenly and unexpectedly and had no 
known coronary heart disease had at least one ECG abnor- 
mality on their last examination. Furthermore, these nonspe- 
cific ST-T abnormalities were shown (20) to influence age- 
adjusted rates of development of every clinical manifestation 
of coronary heart disease. 
In a study of 18,403 civil servants aged 40 to 64 years, Rose 
and coworkers (8) found that even a minor T wave inversion or 
flattening as a single finding was a predictor of coronary heart 
disease mortality. The Busselton study (4), the Copenhagen 
City Heart Study (5) and the British Regional Heart Study (22) 
all disclosed increased cardiovascular mortality among those 
with ST segment or T wave changes. In a study from Finland 
(6), isoelectric or small negative T waves appeared to be as 
important risk indicators as the best known conventional risk 
factors of coronary heart disease, smoking, serum cholesterol 
and blood pressure. Schouten and coworkers (3) studied minor 
ST abnormalities in lead I among 1,953 civil servants in 
Amsterdam and demonstrated increased mortality among men 
with ST segment depression. However, in none of these studies 
were participants with overt coronary heart disease sought for 
and excluded from the analysis. 
Study limitations. Our study has three important limita- 
tions. 1) The overall response rate in the Reykjavik study was 
71%; thus, 29% of those invited were never examined. Al- 
though these data are comparable with those of several other 
large epidemiologic studies (23,24), this is an obvious limita- 
tion because those who do not undergo examination may differ 
in several respects from those who do. 2). Data from this study 
of men cannot be extrapolated to the prognostic and clinical 
impact of silent ECG ST-T changes in women. Those will be 
the subject of a subsequent report. 3) The study was limited to 
an epidemiologic and natural history approach, and no further 
definition of possible perfusion defects or truly silent ischemia 
(25) was attempted. 
Conclusions. The results presented here confirm the im- 
portance of silent ST segment or T wave changes in men who 
have no clinical evidence of coronary heart disease after 
thorough clinical examination and careful scrutiny of hospital 
records. Although not specific for coronary heart disease and 
often transient, hese changes are possible markers of a silent 
coronary heart disease and predictors of reduced survival. A 
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strong association with hypertension was found but, after 
accounting for this and multiple other confounding factors, the 
ST-T changes independently contributed to death from coro- 
nary heart disease, and they are known to be associated with 
increased risk of sudden death and the development of every 
clinical manifestation of coronary heart disease. Although the 
survival probability of these men is better than that of men with 
overt disease, they comprise a larger group. In view of recent 
achievements in secondary prevention (15), they ought to be 
recognized and further evaluated with respect to coronary 
heart disease. 
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